REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $800,000 | +29268.6% | 250,000 | -1.3% | 0.14% | -67.1% |
| Q1 2023 | $2,724 | -98.4% | 253,400 | +704.4% | 0.43% | +3772.7% |
| Q3 2022 | $168,000 | +1580.0% | 31,500 | +176.3% | 0.01% | +1000.0% |
| Q2 2022 | $10,000 | +11.1% | 11,400 | -21.4% | 0.00% | – |
| Q4 2021 | $9,000 | -99.6% | 14,500 | -85.0% | 0.00% | -100.0% |
| Q2 2020 | $2,356,000 | +33557.1% | 96,480 | +793.3% | 0.13% | – |
| Q1 2020 | $7,000 | 0.0% | 10,800 | -57.8% | 0.00% | – |
| Q4 2019 | $7,000 | – | 25,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
| Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
| Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
| ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
| Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
| Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
| Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |